924 related articles for article (PubMed ID: 30803729)
1. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
Ljungberg B; Albiges L; Abu-Ghanem Y; Bensalah K; Dabestani S; Fernández-Pello S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Kuusk T; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Tahbaz R; Volpe A; Bex A
Eur Urol; 2019 May; 75(5):799-810. PubMed ID: 30803729
[TBL] [Abstract][Full Text] [Related]
2. EAU guidelines on renal cell carcinoma: 2014 update.
Ljungberg B; Bensalah K; Canfield S; Dabestani S; Hofmann F; Hora M; Kuczyk MA; Lam T; Marconi L; Merseburger AS; Mulders P; Powles T; Staehler M; Volpe A; Bex A
Eur Urol; 2015 May; 67(5):913-24. PubMed ID: 25616710
[TBL] [Abstract][Full Text] [Related]
3. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.
Ljungberg B; Albiges L; Abu-Ghanem Y; Bedke J; Capitanio U; Dabestani S; Fernández-Pello S; Giles RH; Hofmann F; Hora M; Klatte T; Kuusk T; Lam TB; Marconi L; Powles T; Tahbaz R; Volpe A; Bex A
Eur Urol; 2022 Oct; 82(4):399-410. PubMed ID: 35346519
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer.
Albiges L; Choueiri T; Escudier B; Galsky M; George D; Hofmann F; Lam T; Motzer R; Mulders P; Porta C; Powles T; Sternberg C; Bex A
Eur Urol; 2015 Jan; 67(1):100-110. PubMed ID: 24841777
[TBL] [Abstract][Full Text] [Related]
5. Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel.
Abu-Ghanem Y; Fernández-Pello S; Bex A; Ljungberg B; Albiges L; Dabestani S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Kuusk T; Marconi L; Merseburger AS; Tahbaz R; Staehler M; Volpe A; Powles T; Lam TB; Bensalah K
Eur Urol Oncol; 2020 Aug; 3(4):433-452. PubMed ID: 32245655
[TBL] [Abstract][Full Text] [Related]
6. Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.
Fernández-Pello S; Hora M; Kuusk T; Tahbaz R; Dabestani S; Abu-Ghanem Y; Albiges L; Giles RH; Hofmann F; Kuczyk MA; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Volpe A; Ljungberg B; Bex A; Bensalah K
Eur Urol Oncol; 2020 Feb; 3(1):57-72. PubMed ID: 31171501
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for the Management of Rare Kidney Cancers.
Giles RH; Choueiri TK; Heng DY; Albiges L; Hsieh JJ; Linehan WM; Pal S; Maskens D; Paseman B; Jonasch E; Malouf G; Molina AM; Pickering L; Shuch B; Srinivas S; Srinivasan R; Tannir NM; Bex A
Eur Urol; 2017 Dec; 72(6):974-983. PubMed ID: 28720391
[TBL] [Abstract][Full Text] [Related]
8. [European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract].
Rouprêt M; Zigeuner R; Palou J; Boehle A; Kaasinen E; Sylvester R; Babjuk M; Oosterlinck W;
Actas Urol Esp; 2012 Jan; 36(1):2-14. PubMed ID: 22036956
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma guideline.
Ljungberg B; Hanbury DC; Kuczyk MA; Merseburger AS; Mulders PF; Patard JJ; Sinescu IC;
Eur Urol; 2007 Jun; 51(6):1502-10. PubMed ID: 17408850
[TBL] [Abstract][Full Text] [Related]
10. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
[TBL] [Abstract][Full Text] [Related]
11. The current management of renal cell carcinoma.
Kuusk T; Grivas N; de Bruijn R; Bex A
Minerva Med; 2017 Aug; 108(4):357-369. PubMed ID: 28176516
[TBL] [Abstract][Full Text] [Related]
12. Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma.
Bex A; Albiges L; Ljungberg B; Bensalah K; Dabestani S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Lam TB; Marconi L; Merseburger AS; Staehler M; Volpe A; Powles T
Eur Urol; 2017 May; 71(5):719-722. PubMed ID: 27986369
[TBL] [Abstract][Full Text] [Related]
13. EAU guidelines on renal cell carcinoma: the 2010 update.
Ljungberg B; Cowan NC; Hanbury DC; Hora M; Kuczyk MA; Merseburger AS; Patard JJ; Mulders PF; Sinescu IC;
Eur Urol; 2010 Sep; 58(3):398-406. PubMed ID: 20633979
[TBL] [Abstract][Full Text] [Related]
14. Systematic review of oncological outcomes following surgical management of localised renal cancer.
MacLennan S; Imamura M; Lapitan MC; Omar MI; Lam TB; Hilvano-Cabungcal AM; Royle P; Stewart F; MacLennan G; MacLennan SJ; Canfield SE; McClinton S; Griffiths TR; Ljungberg B; N'Dow J; ;
Eur Urol; 2012 May; 61(5):972-93. PubMed ID: 22405593
[TBL] [Abstract][Full Text] [Related]
15. Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma.
Thorstenson A; Harmenberg U; Lindblad P; Ljungberg B; Lundstam S;
Scand J Urol; 2016; 50(1):2-8. PubMed ID: 26202573
[TBL] [Abstract][Full Text] [Related]
16. European guidelines on upper tract urothelial carcinomas: 2013 update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester R; Burger M; Cowan N; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF;
Eur Urol; 2013 Jun; 63(6):1059-71. PubMed ID: 23540953
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of disease-free survival as an intermediate metric of overall survival in patients with localized renal cell carcinoma: A trial-level meta-analysis.
Harshman LC; Xie W; Moreira RB; Bossé D; Ruiz Ares GJ; Sweeney CJ; Choueiri TK
Cancer; 2018 Mar; 124(5):925-933. PubMed ID: 29266178
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review of the Management of Local Kidney Cancer Relapse.
Kriegmair MC; Bertolo R; Karakiewicz PI; Leibovich BC; Ljungberg B; Mir MC; Ouzaid I; Salagierski M; Staehler M; van Poppel H; Wood CC; Capitanio U;
Eur Urol Oncol; 2018 Dec; 1(6):512-523. PubMed ID: 31158097
[TBL] [Abstract][Full Text] [Related]
19. The changing landscape of systemic therapy in metastatic renal cell carcinoma: an update.
Gurram S; Al Harthy M; Ball MW
Discov Med; 2020; 29(158):191-199. PubMed ID: 33007194
[TBL] [Abstract][Full Text] [Related]
20. Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma.
Williamson TJ; Pearson JR; Ischia J; Bolton DM; Lawrentschuk N
BJU Int; 2016 Apr; 117(4):555-62. PubMed ID: 26617405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
